Kohei Hashimoto

1.4k total citations
90 papers, 991 citations indexed

About

Kohei Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kohei Hashimoto has authored 90 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 21 papers in Oncology. Recurrent topics in Kohei Hashimoto's work include Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Kohei Hashimoto is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Kohei Hashimoto collaborates with scholars based in Japan, Australia and United States. Kohei Hashimoto's co-authors include Naoya Masumori, Ko Kobayashi, Shin‐ichi Hisasue, Ryuichi Kato, Naoki Itoh, Taiji Tsukamoto, Toshinori Nakayama, Tomio Tada, Dave S.�B. Hoon and Ryuichi Morishita and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Kohei Hashimoto

78 papers receiving 959 citations

Peers

Kohei Hashimoto
Ivo Noci Italy
Moshe Shalev United States
Kristin Delfino United States
Victoria Stewart United Kingdom
Sara Peters United States
Kohei Hashimoto
Citations per year, relative to Kohei Hashimoto Kohei Hashimoto (= 1×) peers Yangzhou Liu

Countries citing papers authored by Kohei Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Kohei Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Hashimoto more than expected).

Fields of papers citing papers by Kohei Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Hashimoto. The network helps show where Kohei Hashimoto may publish in the future.

Co-authorship network of co-authors of Kohei Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Hashimoto. A scholar is included among the top collaborators of Kohei Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Hashimoto. Kohei Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shindo, Tetsuya, Kohei Hashimoto, Shintaro Miyamoto, et al.. (2025). Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study. Journal of Geriatric Oncology. 16(2). 102183–102183. 1 indexed citations
2.
Kato, Takuma, Tohru Yoneyama, Yoichiro Tohi, et al.. (2025). S2,3PSA% as a predictor of reclassification of 1st protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.. Journal of Clinical Oncology. 43(5_suppl). 358–358. 2 indexed citations
3.
Kobayashi, Ko, et al.. (2025). The Change of Nocturnal Penile Tumescence During Dutasteride Administration. International Journal of Urology. 33(1). e70291–e70291.
4.
Tanaka, Toshiaki, et al.. (2024). Development and preliminary evaluation of a novel procedure for creation of an ileal conduit stoma aimed at preventing parastomal hernia. International Journal of Urology. 31(5). 512–518. 1 indexed citations
5.
Kita, Yuki, Katsuhiro Ito, Takuto Hara, et al.. (2024). Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International Journal of Urology. 31(5). 552–559. 13 indexed citations
6.
Hashimoto, Kohei, et al.. (2024). Ideal cystoscopic interval after nephroureterectomy in patients with upper tract urothelial carcinoma. World Journal of Urology. 42(1). 629–629.
8.
Hashimoto, Kohei, Tetsuya Shindo, Sachiyo Nishida, et al.. (2024). Management of apalutamide‐induced rash with focus on early peaks. International Journal of Urology. 32(1). 113–115.
9.
Abe, Takashige, Noriyuki Abe, Junya Abe, et al.. (2024). Gap analysis between trainees' subjective competencies and the competencies expected by instructors in urology: A need assessment survey in Japan. International Journal of Urology. 31(6). 653–661. 1 indexed citations
10.
Izumi, Kouji, Takashi Shima, Koji Mita, et al.. (2022). Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial. European Urology Open Science. 41. 16–23. 7 indexed citations
11.
Tohi, Yoichiro, Ryou Ishikawa, Takuma Kato, et al.. (2022). Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study. International Journal of Clinical Oncology. 28(2). 299–305. 7 indexed citations
12.
Sakai, Yasuyuki, Tetsuya Shindo, Shunsuke Sato, et al.. (2021). Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study. Journal of Bone and Mineral Metabolism. 39(4). 661–667. 3 indexed citations
14.
Tanaka, Toshiaki, Koji Ichihara, Kohei Hashimoto, et al.. (2017). The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis. Clinical and Experimental Nephrology. 21(5). 852–857. 3 indexed citations
15.
Hashimoto, Kohei, Toshiaki Tanaka, Toshihiro Maeda, et al.. (2015). The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells. Laboratory Investigation. 95(3). 283–295. 17 indexed citations
17.
Kobayashi, Ko, Naoya Masumori, Shin‐ichi Hisasue, et al.. (2008). Inhibition of Seminal Emission Is the Main Cause of Anejaculation Induced by a New Highly Selective α1A-Blocker in Normal Volunteers. The Journal of Sexual Medicine. 5(9). 2185–2190. 74 indexed citations
18.
Takayanagi, Akio, Ko Kobayashi, Kohei Hashimoto, et al.. (2008). A CASE OF ANDROGENIC ANABOLIC STEROID ABUSE CAUSED HYPOGONADOTROPIC HYPOGONADISM. The Japanese Journal of Urology. 99(7). 729–732. 8 indexed citations
19.
Binder, Bernd R., Oliver Ebenhöh, Kohei Hashimoto, & R. Heinrich. (2006). Expansion of signal transduction networks. PubMed. 153(5). 364–364. 2 indexed citations
20.
Ho, Angela, Kohei Hashimoto, & Constance L. Chik. (1999). 3′,5′‐Cyclic Guanosine Monophosphate Activates Mitogen‐Activated Protein Kinase in Rat Pinealocytes. Journal of Neurochemistry. 73(2). 598–604. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026